Sumatriptan Tablet
Product Images NDC 68071-3802

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 68071-3802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3802 9)

Sumatriptan 50 mg tablets label from NuCare Pharmaceuticals, Inc. The label states each tablet contains 70 mg Sumatriptan Succinate USP equivalent to 50 mg Sumatriptan. The package contains 9 tablets, labeled for prescription use only (Rx Only). Manufacturer details include Aurobindo Pharma Limited, Hyderabad, India, with storage instructions at controlled temperature 68-77°F. The label includes multiple barcodes, lot number, expiration date placeholders, and a warning to keep out of reach of children.*

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

A line graph illustrating the estimated probability of response over time in minutes from the initial dose for placebo, 25 mg, 50 mg, and 100 mg doses. The vertical axis measures estimated probability of response (0% to 100%), and the horizontal axis measures time from 0 to 240 minutes, with response probability increasing over time for active doses compared to placebo.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Sumatriptan Fig2)

A line graph showing the estimated probability of remedication or rescue over 24 hours from the initial dose. It includes curves for placebo and three doses of Sumatriptan (25 mg, 50 mg, and 100 mg), illustrating increasing probability with higher doses and time.*

FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical structure diagram of Sumatriptan Succinate showing its molecular composition and arrangement of atoms, including indole and sulfonamide groups, consistent with the active ingredient in Sumatriptan 50 mg oral tablets by NuCare Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.